Publications by authors named "Kevin Gunn"

Claim this Profile
D
Discovery of Vixotrigine: A Novel Use-Dependent Sodium Channel Blocker for the Treatment of Trigeminal Neuralgia.
David R Witty, Giuseppe Alvaro, Dominique Derjean, Gerard M P Giblin, Kevin Gunn

ACS Med Chem Lett· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of a Nav1.7 selective sodium channel blocker in patients with trigeminal neuralgia: a double-blind, placebo-controlled, randomised withdrawal phase 2a trial.
Joanna M Zakrzewska, Joanne Palmer, Valerie Morisset, Gerard Mp Giblin, Mark Obermann, Kevin Gunn

Lancet Neurol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel design for a phase IIa placebo-controlled, double-blind randomized withdrawal study to evaluate the safety and efficacy of CNV1014802 in patients with trigeminal neuralgia.
Joanna M Zakrzewska, Joanne Palmer, Dominik A Ettlin, Mark Obermann, Gerard M P Giblin, Kevin Gunn

Trials· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis